Literature DB >> 2113879

Chicken IgL variable region gene conversions display pseudogene donor preference and 5' to 3' polarity.

W T McCormack1, C B Thompson.   

Abstract

Chicken immunoglobulin variable region diversity is generated during B-cell development in the bursa of Fabricius by intrachromosomal gene conversion, resulting in the replacement of sequence blocks within the unique rearranged VL1 and VH1 genes with homologous sequences derived from V region pseudogene segments (psi V). In this report, the nucleotide sequences of 217 gene conversion events in 52 random IgL clones were analyzed to characterize the molecular mechanism of gene conversion. The frequency of psi VL usage as gene conversion donors is shown to depend on the proximity of the psi VL segment to VL1, extent of homology with VL1, and relative orientation of the psi VL segments. Gene conversion events are not observed in the 5' region of homology between psi VL segments and VL1, but are distributed throughout the remainder of the VL1 exon. The 5' ends of individual gene conversion events always begin in regions of homology between the donor psi VL and recipient VL1 gene, whereas the 3' ends can occur in regions of nonhomology and often have nucleotide insertions or deletions. These results suggest a 5' to 3' polarity in the gene conversion mechanism. The implications of our data are discussed in relation to current molecular models of gene conversion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2113879     DOI: 10.1101/gad.4.4.548

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  35 in total

1.  A double-strand break in a chromosomal LINE element can be repaired by gene conversion with various endogenous LINE elements in mouse cells.

Authors:  A Tremblay; M Jasin; P Chartrand
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Construction of recombinant monoclonal antibodies from a chicken hybridoma line secreting specific antibody.

Authors:  N Nakamura; Y Aoki; H Horiuchi; S Furusawa; H I Yamanaka; T Kitamoto; H Matsuda
Journal:  Cytotechnology       Date:  2000-03       Impact factor: 2.058

Review 3.  Evolution of V genes: DNA sequence structure of functional germline genes and pseudogenes.

Authors:  H S Rothenfluh; R V Blanden; E J Steele
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

4.  The antigen-binding characteristics of mAbs derived from in vivo priming of avian B cells.

Authors:  N Michael; M A Accavitti; E Masteller; C B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

5.  Gene conversion plays the major role in controlling the stability of large tandem repeats in yeast.

Authors:  S Gangloff; H Zou; R Rothstein
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

Review 6.  Gene conversion in the chicken immunoglobulin locus: a paradigm of homologous recombination in higher eukaryotes.

Authors:  O Y Bezzubova; J M Buerstedde
Journal:  Experientia       Date:  1994-03-15

7.  A novel yeast gene, THO2, is involved in RNA pol II transcription and provides new evidence for transcriptional elongation-associated recombination.

Authors:  J I Piruat; A Aguilera
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

8.  Chicken T-cell receptor beta-chain diversity: an evolutionarily conserved D beta-encoded glycine turn within the hypervariable CDR3 domain.

Authors:  W T McCormack; L W Tjoelker; G Stella; C E Postema; C B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

9.  Patterns of receptor revision in the immunoglobulin heavy chains of a teleost fish.

Authors:  Miles D Lange; Geoffrey C Waldbieser; Craig J Lobb
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

10.  RAD51 paralogs promote homology-directed repair at diversifying immunoglobulin V regions.

Authors:  Ellen C Ordinario; Munehisa Yabuki; Priya Handa; W Jason Cummings; Nancy Maizels
Journal:  BMC Mol Biol       Date:  2009-10-28       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.